Craft

Neurometrix

Stock Price

$4

2024-10-29

Market Capitalization

$8.2 M

2024-10-29

Revenue

$3 M

FY, 2024

Neurometrix Summary

Company Summary

Overview
NeuroMetrix is a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes. The Company currently markets products for the detection, diagnosis, and monitoring of diabetic neuropathies such as diabetic peripheral neuropathy and median neuropathy (carpal tunnel syndrome).
Type
Public
Status
Active
Founded
1996
HQ
Woburn, MA, US | view all locations
Website
http://www.neurometrix.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • David E. Goodman
  • Shai N. Gozani

    Shai N. Gozani, President, Chief Executive Officer, Chairman of the Board

  • Thomas T. Higgins

    Thomas T. Higgins, Senior Vice President, Chief Financial Officer

  • Nancy E. Katz

LocationsView all

1 location detected

  • Woburn, MA HQ

    United States

    4 Gill St

Neurometrix Financials

Summary Financials

Revenue (FY, 2024)
$3.0M
Gross profit (FY, 2024)
$1.7M
Net income (FY, 2024)
($7.8M)
Cash (FY, 2024)
$1.4M
EBIT (FY, 2024)
($8.8M)
Enterprise value
$6.9M

Footer menu